SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : Amazon.com, Inc. (AMZN) -- Ignore unavailable to you. Want to Upgrade?

To: John K_k who wrote (150280)11/19/2002 10:39:07 AM
From: Victor Lazlo  Respond to of 164684
 
JOhn ELAB is a generic drug co, went public last may. The co's product mix is steadily trending toward their newer, highest margin products. Solid margins, excellent growth, and new approvals by the FDA. ELAB has not even touched the cash they raised in the ipo.

The generic drug sector is very strong these days. The Bush admin is in favor of including genric drugs as part of a health care reform bill.

good luck
Victor


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News